$4.45
-0.14-3.05%
At close: -
$4.45
0.000.00%
After Hours: Dec 27, 4:00 PM EDT
Comments
Loading...
Ironwood Pharmaceuticals (IRWD) Forecast
NewsEarningsIronwood Pharmaceuticals (IRWD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Quotes, Forecast and News Summary
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ironwood Pharmaceuticals (IRWD) stock?
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) through any online brokerage.
Who are Ironwood Pharmaceuticals (IRWD) competitors?
Other companies in Ironwood Pharmaceuticals’s space includes: Immunome (NASDAQ:IMNM), Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Cogent Biosciences (NASDAQ:COGT) and Immatics (NASDAQ:IMTX).
What is the forecast, or price target, for Ironwood Pharmaceuticals (IRWD) stock?
Ironwood Pharmaceuticals has a consensus price target of $13.83.
What is the current price for Ironwood Pharmaceuticals (IRWD)?
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $4.45 last updated December 27, 2024 at 4:00 PM EST.
Does Ironwood Pharmaceuticals (IRWD) pay a dividend?
There are no upcoming dividends for Ironwood Pharmaceuticals.
When is Ironwood Pharmaceuticals (NASDAQ:IRWD) reporting earnings?
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 13, 2025.
Is Ironwood Pharmaceuticals (IRWD) going to split?
There is no upcoming split for Ironwood Pharmaceuticals.
What sector and industry does Ironwood Pharmaceuticals (IRWD) operate in?
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.